Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Burkitt Lymphoma 22Dendritic Cell Sarcoma, Interdigitating 21Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 19Lymphoma, B-Cell, Marginal Zone 19Lymphoma, Follicular 18Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 18Sarcoma 17Lymphoma, Large-Cell, Immunoblastic 17Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Acute 17Recurrence 16Hodgkin Disease 16Leukemia 15Myelodysplastic Syndromes 14Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Neuroectodermal Tumors, Primitive, Peripheral 11Neuroblastoma 11Multiple Myeloma 11Congenital Abnormalities 11Sarcoma, Ewing 10Myeloproliferative Disorders 10Waldenstrom Macroglobulinemia 9Rhabdomyosarcoma 9Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Blast Crisis 9

Interventions

pembrolizumab 2Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2tocilizumab 1poly ICLC 1flt3 ligand protein 1daromun 1SUB1 protein, human 1Radiotherapy 1Radiation 1Mohs Surgery 1Melphalan 1Ipilimumab 1IPI-926 1Capecitabine 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × Melphalan × Sarcoma × Clear all
NCT02507076 2015-07-23

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Albert Einstein College of Medicine

Phase NA Withdrawn
DermatologicSarcoma

Carcinoma, Basal Cell, Melanoma, Sarcoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡